<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">UNITED STATES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SECURITIES AND EXCHANGE COMMISSION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Washington, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FORM 8-K</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CURRENT REPORT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Pursuant to Section 13 or 15(d) of the</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Securities Exchange Act of 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported)
September 11, 2012</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">---------------------------</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Citigroup Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">--------------------------------------------------------------------------------</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Delaware</TD>
    <TD STYLE="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">1-9924</TD>
    <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">52-1568099</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">---------------</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">-----------</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">-------------------</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(State or other</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(Commission</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(IRS Employer</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;jurisdiction of</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">File Number)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Identification No.)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">incorporation)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">399 Park Avenue, New York, New York 10022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">--------------------------------------------------------------------------------</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices)
(Zip Code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(212) 559-1000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">--------------------------------------------------------------------------------</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant's telephone number, including
area code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&#168;</FONT>  Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&#168;</FONT>  Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&#168;</FONT>  Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&#168;</FONT>  Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 50%">&nbsp;</TD><TD STYLE="text-align: right; width: 50%"></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Citigroup Inc. Current Report on Form
8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 2.06. Material Impairments.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 8.01. Other Events.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On September 11, 2012, Citigroup Inc. and Morgan Stanley entered
into an agreement (the &ldquo;Agreement&rdquo;) to amend the Amended and Restated Limited Liability Company Agreement (the &ldquo;JV
Agreement&rdquo;) of Morgan Stanley Smith Barney Holdings LLC (the &ldquo;MSSB JV&rdquo;) providing that, among other things:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(i) Morgan Stanley will pay to Citi $1.89 billion for the
additional 14% interest (the &ldquo;14% Interest&rdquo;) in the MSSB JV as to which Morgan Stanley exercised its initial purchase
option on June 1, 2012, inclusive of the related approximately $5.5 billion of deposits, which will be transferred at no premium.
The purchase price of the 14% Interest is based on an implied 100% valuation of the MSSB JV of $13.5 billion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(ii) Morgan Stanley has agreed, subject to obtaining regulatory
approval, to purchase from Citi the remaining 35% interest in the MSSB JV no later than June 1, 2015 at a purchase price of $4.725
billion which is based on the same implied 100% valuation of the MSSB JV of $13.5 billion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(iii) With regard to the purchase of the 35% interest in the
MSSB JV described above, subject to obtaining regulatory approval, Morgan Stanley has agreed to purchase from Citi at least an
additional 15% interest in the MSSB JV no later than June 1, 2013 at a purchase price based on the $13.5 billion implied valuation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Morgan Stanley will use reasonable best efforts to obtain the
necessary regulatory approvals to make the purchases described in (ii) and (iii) above prior to such dates. In connection with
the sales described in (ii) and (iii) above, Citi will transfer to Morgan Stanley the related approximately $48 billion of deposits
(as of May 31, 2012) at no premium.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To the extent Morgan Stanley does not make the purchases described
in (ii) above by June 1, 2015, Citi will retain its right to demand IPO registration in the JV Agreement and its right to put its
remaining interest in the MSSB JV to Morgan Stanley at a purchase price to be determined by the appraisal process set forth in
the JV Agreement, and Morgan Stanley will have the right to require Citi to sell its remaining interest in the MSSB JV to Morgan
Stanley at a purchase price to be determined by the appraisal process set forth in the JV Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the purpose of recording the impact to the third quarter
2012, Citi&rsquo;s carrying value of its 49% interest in the MSSB JV was approximately $11.3 billion. Based on the Agreement, Citi
expects to record a non-cash GAAP charge to net income in the third quarter 2012 of approximately $2.9 billion after-tax ($4.7
billion pre-tax), consisting of (x) a non-cash GAAP charge to net income of approximately $800 million after-tax ($1.4 billion
pre-tax), representing a loss on sale of the 14% Interest, and (y) an other-than-temporary impairment of the carrying value of
its remaining 35% interest in the MSSB JV of approximately $2.1 billion after-tax ($3.3 billion pre-tax). Citi expects the loss
on sale and the impairment charge will impact its third quarter 2012 reported tangible book value and common equity by approximately
$2.9 billion (based on the after-tax amount of the total charge). Further, the loss on sale and the impairment charge would have
had a negative impact on Citi&rsquo;s second quarter 2012 Basel 1 Tier 1 regulatory capital ratios of approximately 37 basis points
(based on the pre-tax amount of the total charge). The impairment will not impact Citi&rsquo;s estimated Basel III capital position;
however, the sale of the 14% Interest to Morgan Stanley is expected to add approximately 14 basis points to Citi&rsquo;s estimated
Tier 1 Common regulatory capital ratio for Basel III capital purposes.<B> </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 50%">&nbsp;</TD><TD STYLE="text-align: right; width: 50%"></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certain statements in this document, including the estimated
other-than-temporary impairment charge in the third quarter 2012, the consummation of the sale of the 14% Interest and the potential
impact of these events on certain of Citi&rsquo;s financial and regulatory capital metrics, are &ldquo;forward-looking statements&rdquo;
within the meaning of the rules and regulations of the U.S. Securities and Exchange Commission. These statements are based on management&rsquo;s
current expectations and are subject to uncertainty and changes in circumstances. Actual results and capital and other financial
condition may differ materially from those included in these statements due to a variety of factors, including but not limited
to the precautionary statements included in this document, the actual sale of the 14% Interest and the remaining interests Citi
holds in the MSSB JV, and the completion of the final analysis of the financial, capital and accounting impact on Citi resulting
from the entry into the Agreement and the sale of the 14% Interest. More information about these factors and other factors that
may affect Citi&rsquo;s future results is contained in Citi&rsquo;s filings with the U.S. Securities and Exchange Commission, including
without limitation the &ldquo;Risk Factors&rdquo; section of Citi&rsquo;s 2011 Annual Report on Form 10-K. Precautionary statements
included in such filings should be read in conjunction with this document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 50%">&nbsp;</TD><TD STYLE="text-align: right; width: 50%"></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: September 11, 2012</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2"><B></B>CITIGROUP INC.</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; width: 50%">&nbsp;</TD>
    <TD STYLE="width: 4%">By:&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 46%">/s/ Rohan Weerasinghe</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>Name:<BR>
Title:&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-top: #000000 1px solid">Rohan Weerasinghe<BR>General Counsel and
Corporate Secretary</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt; margin-top: 0pt; margin-bottom: 6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt; margin-top: 0pt; margin-bottom: 6pt"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 50%">&nbsp;</TD><TD STYLE="text-align: right; width: 50%"></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt; margin-top: 0pt; margin-bottom: 6pt">&nbsp;</P>

</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "v323464_8k.htm", "description": "FORM 8-K", "secsgml_size_bytes": 18890}]
{"company-data": {"conformed-name": "CITIGROUP INC", "cik": "0000831001", "assigned-sic": "6021", "irs-number": "521568099", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-09924", "film-number": "121085144"}, "business-address": {"street1": "399 PARK AVENUE", "city": "NEW YORK", "state": "NY", "zip": "10043", "phone": "2125591000"}, "mail-address": {"street1": "399 PARK AVENUE", "city": "NEW YORK", "state": "NY", "zip": "10043"}, "former-company": [{"former-conformed-name": "TRAVELERS GROUP INC", "date-changed": "19950519"}, {"former-conformed-name": "TRAVELERS INC", "date-changed": "19940103"}, {"former-conformed-name": "PRIMERICA CORP /NEW/", "date-changed": "19920703"}]}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
September 11, 2012
---------------------------
Citigroup Inc.
--------------------------------------------------------------------------------
(Exact name of registrant as specified in
its charter)
Delaware
1-9924
52-1568099
---------------
-----------
-------------------
(State or other
(Commission
(IRS Employer
jurisdiction of
File Number)
Identification No.)
incorporation)
399 Park Avenue, New York, New York 10022
--------------------------------------------------------------------------------
(Address of principal executive offices)
(Zip Code)
(212) 559-1000
--------------------------------------------------------------------------------
(Registrant's telephone number, including
area code)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
Citigroup Inc. Current Report on Form
8-K
Item 2.06. Material Impairments.
Item 8.01. Other Events.
On September 11, 2012, Citigroup Inc. and Morgan Stanley entered
into an agreement (the "Agreement") to amend the Amended and Restated Limited Liability Company Agreement (the "JV
Agreement") of Morgan Stanley Smith Barney Holdings LLC (the "MSSB JV") providing that, among other things:
(i) Morgan Stanley will pay to Citi $1.89 billion for the
additional 14% interest (the "14% Interest") in the MSSB JV as to which Morgan Stanley exercised its initial purchase
option on June 1, 2012, inclusive of the related approximately $5.5 billion of deposits, which will be transferred at no premium.
The purchase price of the 14% Interest is based on an implied 100% valuation of the MSSB JV of $13.5 billion.
(ii) Morgan Stanley has agreed, subject to obtaining regulatory
approval, to purchase from Citi the remaining 35% interest in the MSSB JV no later than June 1, 2015 at a purchase price of $4.725
billion which is based on the same implied 100% valuation of the MSSB JV of $13.5 billion.
(iii) With regard to the purchase of the 35% interest in the
MSSB JV described above, subject to obtaining regulatory approval, Morgan Stanley has agreed to purchase from Citi at least an
additional 15% interest in the MSSB JV no later than June 1, 2013 at a purchase price based on the $13.5 billion implied valuation.
Morgan Stanley will use reasonable best efforts to obtain the
necessary regulatory approvals to make the purchases described in (ii) and (iii) above prior to such dates. In connection with
the sales described in (ii) and (iii) above, Citi will transfer to Morgan Stanley the related approximately $48 billion of deposits
(as of May 31, 2012) at no premium.
To the extent Morgan Stanley does not make the purchases described
in (ii) above by June 1, 2015, Citi will retain its right to demand IPO registration in the JV Agreement and its right to put its
remaining interest in the MSSB JV to Morgan Stanley at a purchase price to be determined by the appraisal process set forth in
the JV Agreement, and Morgan Stanley will have the right to require Citi to sell its remaining interest in the MSSB JV to Morgan
Stanley at a purchase price to be determined by the appraisal process set forth in the JV Agreement.
For the purpose of recording the impact to the third quarter
2012, Citi's carrying value of its 49% interest in the MSSB JV was approximately $11.3 billion. Based on the Agreement, Citi
expects to record a non-cash GAAP charge to net income in the third quarter 2012 of approximately $2.9 billion after-tax ($4.7
billion pre-tax), consisting of (x) a non-cash GAAP charge to net income of approximately $800 million after-tax ($1.4 billion
pre-tax), representing a loss on sale of the 14% Interest, and (y) an other-than-temporary impairment of the carrying value of
its remaining 35% interest in the MSSB JV of approximately $2.1 billion after-tax ($3.3 billion pre-tax). Citi expects the loss
on sale and the impairment charge will impact its third quarter 2012 reported tangible book value and common equity by approximately
$2.9 billion (based on the after-tax amount of the total charge). Further, the loss on sale and the impairment charge would have
had a negative impact on Citi's second quarter 2012 Basel 1 Tier 1 regulatory capital ratios of approximately 37 basis points
(based on the pre-tax amount of the total charge). The impairment will not impact Citi's estimated Basel III capital position;
however, the sale of the 14% Interest to Morgan Stanley is expected to add approximately 14 basis points to Citi's estimated
Tier 1 Common regulatory capital ratio for Basel III capital purposes.
************
Certain statements in this document, including the estimated
other-than-temporary impairment charge in the third quarter 2012, the consummation of the sale of the 14% Interest and the potential
impact of these events on certain of Citi's financial and regulatory capital metrics, are "forward-looking statements"
within the meaning of the rules and regulations of the U.S. Securities and Exchange Commission. These statements are based on management's
current expectations and are subject to uncertainty and changes in circumstances. Actual results and capital and other financial
condition may differ materially from those included in these statements due to a variety of factors, including but not limited
to the precautionary statements included in this document, the actual sale of the 14% Interest and the remaining interests Citi
holds in the MSSB JV, and the completion of the final analysis of the financial, capital and accounting impact on Citi resulting
from the entry into the Agreement and the sale of the 14% Interest. More information about these factors and other factors that
may affect Citi's future results is contained in Citi's filings with the U.S. Securities and Exchange Commission, including
without limitation the "Risk Factors" section of Citi's 2011 Annual Report on Form 10-K. Precautionary statements
included in such filings should be read in conjunction with this document.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: September 11, 2012
CITIGROUP INC.
By:
/s/ Rohan Weerasinghe
Name:
Title:
Rohan Weerasinghe
General Counsel and
Corporate Secretary